{
    "code": "52027195",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027195",
    "time": "2020-06-26 05:20:44",
    "許可證字號": "衛部藥輸字第027195號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/07\/05",
    "發證日期": "106\/07\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202719509",
    "中文品名": "克癌特膜衣錠150毫克",
    "英文品名": "Kapetral F.C. Tablets 150mg",
    "適應症": "乳癌：CAPECITABINE與docetaxel併用於治療對anthracycline化學治療無效之局部晚期或轉移性乳癌病患。CAPECITABINE亦可單獨用於對紫杉醇（taxane）及anthracycline化學治療無效，或無法使用anthracyline治療之局部晚期或轉移性乳癌病患。結腸癌或大腸（結腸直腸）癌：CAPECITABINE可作為第三期結腸癌患者手術後的輔助性療法。CAPECITABINE可治療轉移性大腸（結腸直腸）癌病患。胃癌：CAPECITABINE合併platinum可使用於晚期胃癌之第一線治療。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000錠PVC\/PE\/PVDC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CAPECITABINE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "1206801100  富富企業股份有限公司",
    "申請商地址": "台北市民生東路一段42號五樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FCY0005100  REMEDICA LTD.",
            "製造廠廠址": "AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE , LIMASSOL 3056, CYPRUS",
            "製造廠公司地址": "",
            "製造廠國別": "CYPRUS",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037200",
            "成分名稱": "CAPECITABINE",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "52027195-106-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027195&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20200221_Kapetral 150mg and 500mg tablets仿單-109-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027195&Seq=002&Type=9"
        },
        {
            "title": "520271950005-106-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027195&Seq=003&Type=8"
        },
        {
            "title": "520271950004-106-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027195&Seq=002&Type=8"
        },
        {
            "title": "520271950003-106-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027195&Seq=001&Type=8"
        }
    ]
}